Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Alex Michotte actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Onderzoeksoutput
-
Mitotic count is prognostic in IDH-mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trials 26053 and EORTC 22033-26033
Kros, J. M., Rushing, E., Uwimana, A. L., Hernández-Laín, A., Michotte, A., Al-Hussaini, M., Bielle, F., Mawrin, C., Marucci, G., Tesileanu, C. M. S., Stupp, R., Baumert, B., van den Bent, M., French, P. J. & Gorlia, T., 3 aug 2023, In: Neuro-oncology. 25, 8, blz. 1443-1449 7 blz.Onderzoeksoutput: Article › peer review
2 Citaten (Scopus) -
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB)
Schwarze, J. K., Geens, W., Tijtgat, J., Awada, G., Vanbinst, A., Everaert, H., Seynaeve, L., Michotte, A., Bruneau, M., VAN RIET, I., Tuyaerts, S., Duerinck, J. & Neyns, B., 3 jun 2022.Onderzoeksoutput: Poster
-
Quality indicators in neuro-oncology: Review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey
QINO consortium, Vanhauwaert, D., Pinson, H., Sweldens, C., Du Four, S., Van Eycken, L., De Schutter, H., De Vleeschouwer, S., Boterberg, T. & Michotte, A., apr 2022, In: Journal of Neuro-Oncology. 157, 2, blz. 365-376 12 blz.Onderzoeksoutput: Article › peer review
1 Citaat (Scopus) -
A novel KCNK9 missense variant outside the classic p.Gly236 substitution causes Birk Barel syndrome
Uyttebroeck, S., Wassenberg, T., Michotte, A., Cooreman, R., Keymolen, K., Hes, F. J. & Poelsler, L., 17 sep 2021.Onderzoeksoutput: Poster
-
Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial
Duerinck, J., Schwarze, J. K., Awada, G., Tijtgat, J., Vaeyens, F., Bertels, C., Geens, W., Klein, S., Seynaeve, L., Cras, L., D'Haene, N., Michotte, A., Caljon, B., Salmon, I., Bruneau, M., Kockx, M., Van Dooren, S., Vanbinst, A-M., Everaert, H., Forsyth, R. & 1 anderen, , jun 2021, In: Journal for immunotherapy of cancer. 9, 6, 11 blz., e002296.Onderzoeksoutput: Article › peer review
Open Access29 Citaten (Scopus)
Activiteiten
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
Wietse Geens (Speaker), Julia Katharina Schwarze (Contributor), Cleo Bertels (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), F Vaeyens (Contributor), Louise Cras (Contributor), Anne Vanbinst (Contributor), Hendrik Everaert (Contributor), Alex Michotte (Contributor), Toon Janssen (Contributor), Ben Caljon (Contributor), Thomas Cauwenbergh (Contributor), Michaël Bruneau (Contributor), Ramses Forsyth (Contributor), Sandra Tuyaerts (Contributor), Bart Neyns (Contributor) & Johnny Duerinck (Contributor)
26 mrt 2022Activiteit: Talk or presentation at a conference
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
Wietse Geens (Speaker), Julia Katharina Schwarze (Contributor), Cleo Bertels (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), F Vaeyens (Contributor), Louise Cras (Contributor), Anne Vanbinst (Contributor), Hendrik Everaert (Contributor), Alex Michotte (Contributor), Toon Janssen (Contributor), Ben Caljon (Contributor), Thomas Cauwenbergh (Contributor), Michaël Bruneau (Contributor), Ramses Forsyth (Contributor) & Bart Neyns (Contributor)
26 mrt 2022Activiteit: Talk or presentation at a conference
-
Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): a multi-cohort adaptive phase I clinical trial
Julia Katharina Schwarze (Speaker), Wietse Geens (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), Anne-Marie Van Binst (Contributor), Hendrik Everaert (Contributor), Laura Seynaeve (Contributor), Alex Michotte (Contributor), Michaël Bruneau (Contributor), I VAN RIET (Contributor), Sandra Tuyaerts (Contributor), Johnny Duerinck (Contributor) & Bart Neyns (Contributor)
16 sep 2021 → 21 sep 2021Activiteit: Talk or presentation at a conference
-
LOK vergadering neurologie 2021/2
Alex Michotte (Organiser), Veronique Bissay (Participant), Anja Flamez (Participant), Ann De Smedt (Participant), Ilse Peeters (Participant), Jan Versijpt (Participant), Miguel D'Haeseleer (Participant), Sebastiaan Engelborghs (Participant), Ayla Pauwels (Participant), Sylvie De Raedt (Participant) & Ann Katrijn M Cordenier (Participant)
3 jun 2021Activiteit: Participation in workshop, seminar
-
LOK vergadering neurologie 2021/3
Alex Michotte (Organiser), Veronique Bissay (Participant), Anja Flamez (Participant), Ann De Smedt (Participant), Guy Nagels (Participant), Jan Versijpt (Participant), Miguel D'Haeseleer (Participant), Sebastiaan Engelborghs (Participant), Sylvie De Raedt (Participant) & Wietse Wiels (Participant)
7 okt 2021Activiteit: Participation in workshop, seminar